Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors

… an oncology-focused Asian biotechnology company committed to developing … drugs. Headquartered in Singapore, AUM is strategically … SINGAPORE NORTH AMERICA IRELAND ASIA PACIFIC EUROPE INDUSTRY KEYWORD: RESEARCH TECHNOLOGY OTHER TECHNOLOGY BIOTECHNOLOGY …